drugset / Trial / NCT00417261
Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.
RandomizedCrossoverQuadruple-blindTreatment
Summary
This is a first-in-human study and is designed to evaluate the safety, tolerability, pharmacodynamic and pharmacokinetic effects of a single and multiple-doses of ATF936 and AXT914 administered orally in healthy subjects.
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATF936 | Small molecule | — | Oral |
| Subject | AXT914 | Small molecule | — | Oral |
Indications
No indication recorded.